Table 2.
Exposures Included in the Model | Meningioma |
Glioma/PNET |
||||
---|---|---|---|---|---|---|
Deviance | df | LRT P | Deviance | df | LRT P | |
Null model | 127.54 | 92 | 81.79 | 59 | ||
Radiation, Gy* | 50.83 | 91 | < .001† | 69.58 | 58 | < .001† |
Radiation* + alkylating agents mg/m2* | 49.47 | 90 | .245‡ | 69.55 | 57 | .864‡ |
Radiation* + anthracyclines* | 50.58 | 90 | .621‡ | 68.89 | 57 | .407‡ |
Radiation* + intrathecal methotrexate* | 44.87 | 90 | .015‡ | 68.81 | 57 | .379‡ |
Radiation* + nonintrathecal antimetabolites* | 49.22 | 90 | .205‡ | 69.24 | 57 | .561‡ |
Radiation* + epipodophyllotoxins* | 49.69 | 90 | .287‡ | 68.96 | 57 | .429‡ |
Radiation* + vinca alkaloids* | 48.12 | 90 | .100‡ | 69.55 | 57 | .854‡ |
NOTE. Radiation dosed in Gy; chemotherapeutic drugs dosed in milligrams per meter squared.
Abbreviations: ERR, excess relative risk; PNET, primitive neuroectodermal tumor; df, degrees of freedom; LRT, likelihood ratio test.
Fitted as a linear trend in continuous dose (model 1).
LRT P value relative to null model.
LRT P value relative to model with radiation fitted as a linear trend in continuous dose.